Readers like you keep news free for everyone.
More than 5,000 readers have already pitched in to keep free access to The Journal.
For the price of one cup of coffee each week you can help keep paywalls away.
Readers like you keep news free for everyone.
More than 5,000 readers have already pitched in to keep free access to The Journal.
For the price of one cup of coffee each week you can help keep paywalls away.
NIAC today recommended a second mRNA booster dose for people aged 65 or over and those who are immunocompromised.
It also announced that it has recommended the approval of the Spikevax vaccine for children aged between six and 11.
This will be the fifth Covid-19 vaccine approved for use in the European Union.
The European Medicines Agency also said that early data suggested the new variant is more infectious than Delta.
If approved, it would be the fifth Covid jab authorised for use within the EU.
The move adds to the European Union’s toolbox of drugs.
It is the first time the shot has been authorised for people under 18.
US experts said there had been reports of people who had the jab developing Guillain-Barre syndrome.
The European Medicines Agency said it reviewed cases of six people who had capillary leak syndrome after they had received the vaccine.
The European Medicines Agency said this could improve the flexibility in countries’ vaccine rollout.
It follows concerns that the vaccine could be linked to extremely rare blood clots.
Several European countries have paused the use of the jab.
The EMA has also been in touch with representatives of the Chinese Sinopharm jab.
Austria announced it would stop using doses from an AstraZenca batch after the 49-year-old nurse died.
Russia said it is ready to provide vaccines for 50 million Europeans.
The single-dose vaccine could be approved as early as next month.
It followed reports in recent weeks that people had died after receiving the vaccine.
This is due to the “significant drop” in the expected deliveries from AstraZeneca.
Despite the supply issues, a European approval for the Astrazeneca vaccine this Friday will pave the way for its rollout in Ireland.
Health Minister Stephen Donnelly had said he had hoped it could arrive sooner.
Developers have said they could adapt the vaccine quickly if a new variant is resistant to it.
A decision on its authorisation could be reached later this month.
The UK today approved its third Covid-19 vaccine.
The date for a decision had been 12 January.
A decision on the approval of the Pfizer/BioNtech is due on 29 December.
The agency says it has launched a full investigation.
The UK formally approved the vaccine yesterday.
The European Medicines Agency said these falsified medicines can cause serious harm.
An Irish woman whose three children have disabilities will give evidence at a public hearing today.
Earlier this month the Department of Health confirmed that they are preparing for a bid to bring the EMA to Ireland.
The European Medicines Agency says codeine, which is converted to morphine in the body, can pose problems for kids.
The European Medicines Agency is investigating the drug Gilenya, used to treat a severe type of multiple sclerosis, to establish if it linked to the deaths of at least 11 patients.
The European Medicines Agency has said there is a link between the drug Pandemrix and the sleeping disorder narcolepsy in young people.
The medication has been taken off the market after European Medicines Agency ruled that the risks outweigh the benefits.